What are the indications, dosing regimens, contraindications, and alternative therapies for fluoroquinolones?

Fluoroquinolones: Clinical Use Guide

Overview

Fluoroquinolones are broad-spectrum antibiotics reserved for specific infections where no safer alternative exists or when oral therapy is needed to replace parenteral treatment. Their use must be restricted due to serious safety concerns and rising resistance patterns 1.

Primary Indications

First-Line Uses (FDA-Approved in Specific Populations)

Urinary Tract Infections:

• Acute uncomplicated cystitis: Ciprofloxacin 250 mg twice daily or levofloxacin 250 mg once daily for 3 days 2
• Pyelonephritis (outpatient): Ciprofloxacin 500 mg twice daily for 7 days OR levofloxacin 750 mg once daily for 5 days 2
  • Critical caveat: Only use when local fluoroquinolone resistance is <10% 2
  • If resistance >10%, give initial IV ceftriaxone 1g before starting oral fluoroquinolone 2
• Complicated UTI in children 1-17 years: Ciprofloxacin is FDA-approved for E. coli infections 1

Bioterrorism/Biological Warfare:

• Tularemia treatment: Ciprofloxacin 400 mg IV every 8 hours OR 750 mg oral every 12 hours for 10 days 3
• Plague treatment: Ciprofloxacin 500 mg oral every 8 hours for 10-14 days 4
• Anthrax postexposure: FDA-approved for inhalation anthrax in all ages 1

Alternative/Off-Label Uses (When No Other Option Exists)

Pediatric Indications (NOT first-line due to arthrotoxicity concerns):

• Chronic suppurative otitis media or malignant otitis externa from Pseudomonas aeruginosa 1
• Osteomyelitis/osteochondritis from P. aeruginosa 1
• Cystic fibrosis exacerbations with P. aeruginosa (ambulatory setting) 1
• Multidrug-resistant tuberculosis 5
• Multidrug-resistant gastrointestinal infections (Shigella, Salmonella, Vibrio cholerae) 1

Respiratory Infections:

• NOT recommended for community-acquired pneumonia as monotherapy except in adults with comorbidities or recent antibiotic exposure 6, 7
• Levofloxacin or moxifloxacin can be used for severe influenza-related pneumonia with enhanced pneumococcal activity 6

Enteric Fever:

• Fluoroquinolones (ciprofloxacin, ofloxacin, gatifloxacin) are first-line for typhoid fever, but resistance is increasing globally 8

Dosing Regimens

Adults (Standard Renal Function)

Ciprofloxacin:

• UTI: 250-500 mg PO twice daily
• Pyelonephritis: 500 mg PO twice daily or 400 mg IV every 8-12 hours
• Severe infections: 400 mg IV every 8 hours 3, 2

Levofloxacin:

• UTI: 250 mg once daily
• Pyelonephritis: 750 mg once daily
• Severe infections: 750 mg IV/PO once daily 5, 2

Moxifloxacin:

• 400 mg once daily (IV or PO) 3, 6

Renal Dose Adjustments

• Levofloxacin: Reduce to 750-1000 mg three times weekly if creatinine clearance <50 mL/min 5
• Ciprofloxacin: Adjust based on creatinine clearance per package insert

Pregnancy

Fluoroquinolones can be used in pregnancy when benefits outweigh risks (contrary to older absolute contraindications):

• Tularemia: Ciprofloxacin 750 mg every 12 hours PO OR levofloxacin 750 mg every 24 hours as first-line 3
• Plague: Ciprofloxacin 500 mg every 8 hours PO as first-line prophylaxis 4
• Older guidelines recommended avoidance due to teratogenic concerns 5, but recent bioterrorism guidelines prioritize maternal survival 3, 4

Pediatrics

Avoid in children <18 years except for life-threatening infections 1:

• Levofloxacin dosing in children: Optimal dose not established for most indications 5
• Use only when multidrug-resistant pathogens exist and no safe alternative available 1

Contraindications

Absolute

• Known QT prolongation or torsades de pointes history 9
• Concurrent use with other QT-prolonging drugs
• Myasthenia gravis (can worsen muscle weakness)

Relative (Use with Extreme Caution)

• Age >60 years + corticosteroid use: 9-fold increased tendinopathy risk 10, 9
• Epilepsy or CNS disorders (seizure risk) 9
• Chronic renal disease (tendinopathy risk) 9
• Children <18 years (cartilage damage in animals) 1, 11
• Pregnancy (use only when no alternative exists) 5

Critical Safety Warnings

Musculoskeletal Toxicity

• Tendinopathy/rupture: Highest risk in elderly, corticosteroid users, renal disease patients 10, 9
• Achilles tendon most commonly affected
• Can occur during or months after treatment

Cardiac Toxicity

• QT prolongation: Monitor ECG if QTc >500 ms 10
• Moxifloxacin has highest QT prolongation risk among fluoroquinolones

Neurologic Effects

• Seizures, tremors, confusion, hallucinations 9
• Peripheral neuropathy (potentially irreversible)

Phototoxicity

• Varies by agent (sparfloxacin highest, ciprofloxacin moderate) 10
• Advise sun protection during treatment

Drug Interactions

• Antacids/divalent cations: Decrease absorption by >50% - separate by ≥2 hours 5
• Theophylline: Ciprofloxacin increases levels significantly 12
• Corticosteroids: Synergistic tendinopathy risk 10, 9

Resistance Considerations

Ciprofloxacin resistance exceeds 20% in E. coli and P. aeruginosa in many regions 10:

• Always obtain cultures before empiric therapy when possible
• Avoid empiric use for UTI if local resistance >10% 2
• Cross-resistance exists among all fluoroquinolones 5
• Campylobacter resistance >80% in some Asian countries 7

Alternative Therapies

For UTI/Pyelonephritis

• First-line alternatives: Trimethoprim-sulfamethoxazole (if susceptible), nitrofurantoin (cystitis only), β-lactams 2
• Severe pyelonephritis: Ceftriaxone 1g IV daily, aminoglycosides 2

For Respiratory Infections

• Community-acquired pneumonia: Amoxicillin, macrolides, doxycycline 6
• Reserve fluoroquinolones for treatment failures or documented resistance

For Pediatric Infections

• Pseudomonas osteomyelitis: Consider prolonged IV therapy with ceftazidime or piperacillin-tazobactam instead 1
• CF exacerbations: IV antipseudomonal β-lactam + aminoglycoside preferred 1

For Bioterrorism

• Tularemia alternatives: Gentamicin, doxycycline 3
• Plague alternatives: Gentamicin, doxycycline 4

Practical Prescribing Algorithm

1. Confirm indication requires fluoroquinolone (no safer alternative exists)
2. Screen for contraindications: Age >60 + steroids, QT prolongation, seizure disorder
3. Check local resistance patterns: If >10% resistance, add initial parenteral agent
4. Obtain cultures before starting (when feasible)
5. Choose shortest effective duration: 3 days for cystitis, 5-7 days for pyelonephritis 2
6. Counsel on tendon pain, sun avoidance, antacid separation
7. Switch to culture-directed narrow-spectrum therapy when results available

The key principle: Fluoroquinolones are powerful but toxic - use them sparingly, briefly, and only when truly necessary 1, 11.